Precision Medicine in Oncology®

The OncLive Precision Medicine in Oncology® condition center page is a comprehensive resource for clinical news and expert insights on precision-focused approaches in patients with cancer, with gene-targeted tyrosine kinase inhibitors and antibody-drug conjugates, checkpoint inhibitors, tumor-infiltrating lymphocyte therapy, and other tailored treatments. This page features news articles, interviews in written and video format, and podcasts that focus on updates and ongoing research with personalized therapies across solid and hematologic tumors.

Latest News

Galleri Multicancer Early Detection Test :   © Bipul Kumar - stock.adobe.com
PATHFINDER 2 Trial Releases Positive Topline Data for Multicancer Early Detection Test

June 19th 2025

Galleri, a multicancer early detection test, demonstrated high positive predictive value and cancer detection in PATHFINDER 2.

The top 5 OncLive videos of the week cover insights in non–small cell lung cancer, small cell lung cancer, and breast cancer.
Five Under 5: Top Oncology Videos for the Week of 6/8

June 15th 2025

The FDA has approved new options in head and neck cancer, lung cancer, and bladder cancer—and more from OncLive this week.
The OncFive: Top Oncology Updates for the Week of 6/8

June 14th 2025

Non–Small Cell Lung Cancer |  Image by Ashling Wahner &  MJH Life Sciences Using AI
TT125-802 Demonstrates Potential in Advanced NSCLC and Solid Tumors

June 13th 2025

The FDA has approved taletrectinib for use in patients with ROS1-positive advanced non–small cell lung cancer.
FDA Approves Taletrectinib for ROS1+ Advanced NSCLC

June 11th 2025

More News